Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Capital Expenditures (2020 - 2025)

Sotera Health has reported Capital Expenditures over the past 6 years, most recently at $50.7 million for Q4 2025.

  • Quarterly results put Capital Expenditures at $50.7 million for Q4 2025, down 23.03% from a year ago — trailing twelve months through Dec 2025 was $138.0 million (down 22.93% YoY), and the annual figure for FY2025 was $138.0 million, down 22.93%.
  • Capital Expenditures for Q4 2025 was $50.7 million at Sotera Health, down from $77.0 million in the prior quarter.
  • Over the last five years, Capital Expenditures for SHC hit a ceiling of $92.7 million in Q3 2022 and a floor of -$30.3 million in Q3 2021.
  • Median Capital Expenditures over the past 5 years was $13.1 million (2023), compared with a mean of $26.5 million.
  • Biggest five-year swings in Capital Expenditures: plummeted 396.63% in 2021 and later soared 2391300.0% in 2022.
  • Sotera Health's Capital Expenditures stood at -$3000.0 in 2021, then soared by 2391300.0% to $71.7 million in 2022, then tumbled by 99.53% to $337000.0 in 2023, then skyrocketed by 19445.99% to $65.9 million in 2024, then decreased by 23.03% to $50.7 million in 2025.
  • The last three reported values for Capital Expenditures were $50.7 million (Q4 2025), $77.0 million (Q3 2025), and -$2.7 million (Q2 2025) per Business Quant data.